use of low molecular weight dermatan solfatoa and specialita'medicines that contain it in therapy and in pprevenzione of pulmonary embolism.

• 1. 联合应用酶抑制剂及其药学组合物在制备治疗和预防动脉硬化、预防和治疗根据杰尔－库姆斯分类法分类的Ⅰ型过敏反应以及治疗和预防与毛囊和表皮角化过度和角质细胞的过度增殖相关的皮肤疾病的药物中的用途 [P] . 中国专利： CN100579582C . 2010.01.13
• 2. 包含脂肪组织来源的分泌物的组合物在制备用于局部治疗或预防个体中痤疮的药物中的用途 [P] . 中国专利： CN103596577B . 2017.02.15
• 3. Pharmaceutical compositions containing low molecular weight dermatan sulfate for the therapy of pulmonary embolism [P] . 美国专利： US5817645A . 1998-10-06

  机译： 包含低分子量硫酸皮肤素的药物组合物，用于治疗肺栓塞

• 4. Use of low molecular weight dermatan sulfate for the manufacture of a medicament for the prevention and therapy of the pulmonary embolism [P] . 欧洲知识产权局专利： EP0784977A1 . 1997-07-23

  机译： 低分子量硫酸皮肤素在制备用于预防和治疗肺栓塞的药物中的用途

• 5. Antithrombotic composition comprising low molecular weight heparin and low molecular weight dermatan sulfate [P] . 日本专利： JP2005505537A . 2005-02-24

  机译： 包含低分子量肝素和低分子量硫酸皮肤素的抗血栓形成组合物

• 1. Combined effect of Traditional Chinese Medicine decoction and low-molecular-weight heparin calcium on the postoperative deep venous thrombosis in patients with lower limb fracture [J] . 张惠煊, 马翰斐, 袁杰 世界中西医结合杂志（英文） . 2015,第001期
• 2. Effects of low molecular weight heparin on the function of blood coagulation and serum levels of TNF-α, CK-MB, CRP of patients with acute exacerbations of chronic obstructive pulmonary diseases and respiratory failur [J] . Yu-Ting Wang, Ni-Wen Yu 海南医科大学学报（英文版） . 2017,第004期
• 3. Effects of low molecular weight heparin on the function of blood coagulation and serum levels of TNF-α, CK-MB, CRP of patients with acute exacerbations of chronic obstructive pulmonary diseases and respiratory failur [J] . Yu-Ting Wang, Ni-Wen Yu 海南医科大学学报(英文版) . 2017,第004期
• 4. Effect of adjuvant low-molecular-weight heparin therapy on placental hypoxia and cell apoptosis in puerperae with severe preeclampsia [J] . Miao Zhou, Rong-Ying Ou 海南医科大学学报（英文版） . 2017,第008期
• 5. Effect of low molecular weight heparin therapy on maternal endothelial injury and placental pathological injury after hypertensive disorder complicating pregnancy [J] . Shan Dong 海南医科大学学报（英文版） . 2017,第015期
• 6. The evaluation of the effects of traditional medicines on cardiopulmonary function during 21 day simulated weightlessness by exercise test [C] . Lu lili, Li yongzhi, Gai yuqing, 55th International Astronautical Congress 2004 vol.3 . 2004
• 7. Design of high molecular weight polymerized hemoglobins for use in transfusion medicine and monocyte/macrophage hemoglobin-based drug delivery systems. [D] . Zhang, Ning. 2011
• 8. Acute renal failure following repeated streptokinase therapy for pulmonary embolism. [O] . R A Pick, B C Joswig, A K Cheung, 1983
• 9. Antifibrotic therapy by sustained release of low molecular weight heparin from poly(lactic-co-glycolic acid) microparticles on bleomycin-induced pulmonary fibrosis in mice [O] . Takashi Saito, Takuya Kotani, Koichi Suzuki 2020

• 1. 低聚木糖的特性及在特殊医学用途配方食品中的应用前景 [C] . Chunhong Zhang ,张春红 ,Junsheng Huo . 2017中国首届生物发酵健康产业创新高峰论坛 . 2017
• 2. IVCF联合AngioJet药物机械偶联清除下肢深静脉血栓预防肺栓塞 [A] . 朱益强 . 2019